Colonic mucosal lesions associated with long-term administration of non-steroidal anti-inflammatory drugs

Alimentary Pharmacology and Therapeutics Symposium Series

Volumn 2, Issue 1, 2006, Pages 88-95

  Ohkusa, T ^a   Terai, T ^a   Abe, S ^a   Kobayashi, O ^a   Beppu, K ^a   Sakamoto, N ^a   Kurosawa, A ^a   Osada, T ^a   Hojo, M ^a   Nagahara, A ^a   Ogihara, T ^a   Sato, N ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DICLOFENAC; MELOXICAM; NONSTEROID ANTIINFLAMMATORY AGENT;

ABDOMINAL PAIN; ADULT; AGED; ANEMIA; AORTITIS; COLON HEMORRHAGE; COLON INJURY; COLONOSCOPY; CONFERENCE PAPER; CONSTIPATION; CONTROLLED STUDY; DESCENDING COLON; DIARRHEA; FEMALE; FEVER; HEMATOCHEZIA; HUMAN; ISCHEMIC COLITIS; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NAUSEA; PREVALENCE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RHEUMATOID ARTHRITIS; SIDE EFFECT; SIGMOID; TREATMENT DURATION; ULCER; WEIGHT REDUCTION;

EID: 34247897117     PISSN: 17466334     EISSN: 17466342     Source Type: Journal    
DOI: 10.1111/j.1746-6342.2006.00030.x     Document Type: Conference Paper

References (25)

1. Antiplatelet Trialist' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy. I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994 308:81 106.
2. Steering Committee of the Physicians' Health Study Research Group. Final report on the aspirin component of the ongoing Physician's Health Study. N Engl J Med 1989 323:1289 98.
3. The SALT Collaborative Group. Swedish aspirin low-dose trial (SALT) of 75 mgr aspirin as secondary prophylaxis after cerebrovascular events. Lancet 1991 338:1345 53.
4. Lorenz RL, Schacky CV, Weber M, et al. Improved aortocoronary bypass patency by low-dose aspirin (100 mgr. daily): effects of platelet aggregation and thromboxane formation. Lancet 1984 1:1261 4.
5. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A, Willett WC. Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med 1994 121:241 6.
6. Langman MJ, Cheng KK, Gilman EA, Lancashire RJ. Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database. BMJ 2000 320:1642 6.
7. Daves NM. Toxicity of nonsteroidal anti-inflammatory drugs in the large intestine. Dis Colon Rectum 1995 38:1311 21.
8. Gibson GR, Whitacre EB, Ricotti CA. Colitis induced by nonsteroidal anti-inflammatory drugs. Arch Intern Med 1992 152:625 32.
9. Carratu R, Parisi P, Agozzino A. Segmental ischemic colitis associated with nonsteroidal antiinflammatory drugs. J Clin Gastroenterol 1993 16:31 4.
10. Soll AH, Weinstein WM, Kurata J, McCarthy D. Nonsteroidal anti-inflammatory drugs and peptic ulcer disease. Ann Intern Med 1991 114:307 19.
11. McCarthy DM. Nonsteroidal antiinflammatory drug-induced ulcers: management by traditional therapies. Gastroenterology 1989 96:662 74.
12. Loeb DS, Talley NJ, Ahlquist DA, Carpenter HA, Zinsmeister AR. Long-term nonsteroidal anti-inflammatory drug use and gastroduodenal injury: the role of Helicobacter pylori. Gastroenterology 1992 102:1899 905.
13. Graham DY, Lidsky MD, Cox AM, et al. Long-term nonsteroidal antiinflammatory drug use and Helicobacter pylori infection. Gastroenterology 1991 100:1653 7.
14. Tanner AR, Raghunath AS. Colonic inflammation and nonsteroidal anti-inflammatory drug administration. An assessment of the frequency of the problem. Digestion 1988 41:116 20.
15. Bjarnason I, Hayllar J, MacPherson AJ, Russell AS. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology 1993 104:1832 47.
16. Jacobson ED, Stephens JK, Levine JS. Mesenteric ischemia. In:Yamada T, ed. Textbook of Gastroenterology, 3rd edn. Philadelphia:Lippincott Williams & Wilkins, 1999:2594 6.
17. Rogers AI, David S. Intestinal blood flow and disease of vascular impairment. In:Haubrich WS, Schaffner F, Berk JE, eds. Bockus Gastroenterology, 5th edn. Philadelphia, Pennsylvania:W.B. Saunders Co, 1995:665 84.
18. Goldstein NS, Cinenza AN. The histopathology of nonsteroidal anti-inflammatory drug-associated colitis. Am J Clin Pathol 1998 110:622 8.
19. Yao T, Matsumoto T, Iida M, et al. Histologic features of non-steroidal anti-inflammatory drug (NSAID) induced colitis. I to Cho 2000 35:1159 67 (In Japanese, English abstract).
20. Banerjee AK, Perts TJ. Crohn's disease and NSAID enteropathy. A unifying model [Letter]. Gastroenterology 1990 99:1190 2.
21. Rampton DS. Non-steroidal anti-inflammatory drugs and lower gastrointestinal tract. Scand J Gastroenterol 1987 22:1 4.
22. Kitahora T, Guth PH. Effect of aspirin plus hydrochloric acid on the gastric mucosal microcirculation. Gastroenterology 1987 93:810 7.
23. Sartor RB, Murphy ME, Rydzak E. Miscellaneous inflammatory and structural disorders of the colon. In:Yamada T, ed. Textbook of Gastroenterology, 3rd edn. Philadelphia:Lippincott Williams & Wilkins, 1999:1869 70.
24. Monahan DW, Starnes EC, Parker AL. Colonic strictures in a patient on long-term non-steroidal anti-inflammatory drugs. Gastrointest Endosc 1992 38:385 8.
25. Stamm C, Burkhalter CE, Pearce W, et al. Benign colonic ulcers associated with nonsteroidal antiinflammatory drug ingestion. Am J Gastroenterol 1994 89:2230 3.